• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    A

    Armed Forces Research Institute of Medical Science

    EST. 1959
    1,431论文总数
    5.8万引用总数

    论文量&引用量时间轴

    机构学者

    论文(1432)

    年份
    起
    –
    止
    排序
    1Prime-boost Immunization with Inactivated Human Adenovirus Type 55 Combined with an Adjuvant Enhances Neutralizing Antibody Responses in Mice
    Sang Hwan Seo,Jung-ah Choi,Dae-Im Jung, Yunjeong Park,Eunji Yang, Seohee Jung, Taesoo Kwon,Soon-Hwan Kwon,Manki Song

    BACKGROUND:Human adenovirus type 55 (hAd55) infection can lead to acute respiratory diseases that often present with severe symptoms. Despite its persistent prevalence in military camps and communities, there are no commercially available vaccines or vaccine candidates undergoing clinical evaluation; therefore, there is an urgent need to address this. In this study, we evaluated the immunogenicity of inactivated hAd55 isolates and investigated the effects of adjuvants and various immunization intervals. METHODS AND RESULTS:To select a vaccine candidate, four hAd55 strains (6-9, 6-15 (AFMRI 41014), 28-48 (AFMRI 41013), and 12-164 (AFMRI 41012)) were isolated from infected patients in military camps. Sequence analysis revealed no variation in the coding regions of structural proteins, including pentons, hexons, and fibers. Immunization with inactivated hAd55 isolates elicited robust hAd55-specific binding and neutralizing antibody responses in mice, with adjuvants, particularly alum hydroxide (AH), enhancing antibody titers. Co-immunization with AH also induced hAd14-specific neutralizing antibody responses but did not induce hAd11-specific neutralizing antibody responses. Notably, booster immunization administered at a four-week interval resulted in superior immune responses compared with shorter immunization intervals. CONCLUSIONS:Prime-boost immunization with the inactivated hAd55 isolate and an AH adjuvant shows promise as a potential approach for preventing hAd55-induced respiratory disease. Further research is needed to evaluate the efficacy and safety of these vaccine candidates in preventing hAd55-associated respiratory illnesses.

    2026Virology Journal(2026)引用:3
    引用
    AI阅读
    加入学术空间
    2Impact of Asymptomatic Enteroaggregative Escherichia Coli Infection and Co-Pathogen Burden on Intestinal Barrier Function, Linear Growth, and Cognitive Development in Early Childhood: Insights from a Birth Cohort Study
    Aldo A M Lima, Virginia L S C Urtiga,Samilly A Ribeiro,José Q S Filho, L, Ana E S Alves, Luis F B Lino,Francisco A P Rodrigues, Ana K F Leite,Alexandre Havt,Gagandeep Kang,Margaret N Kosek,

    Enteroaggregative Escherichia coli (EAEC) is a major enteric pathogen in low-resource settings. The aim for the present study is to reanalyze the effects of subclinical EAEC infection, alone or in combination with other pathogens, on intestinal function, growth, and cognition in children aged 0-6 months through molecular diagnosis. A total of 1,659 non-diarrheal stool samples from the Etiology, Risk Factors and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development cohort were analyzed using quantitative polymerase chain reaction testing for 29 enteropathogens. Children were grouped by infection status: EAEC alone or with 1, 2, or ≥3 co-pathogens. Enteroaggregative Escherichia coli and a higher pathogen burden were associated with lower socioeconomic status and greater antibiotic use (P <0.001). Enteroaggregative Escherichia coli with ≥3 co-pathogens was linked to elevated neopterin (β = 687.5; CI: 129.7-1,245.3), increased intestinal permeability (β = 0.41; CI: 0.058-0.77), and a lower length-for-age z-score (β = -0.44; CI: -0.76 to -0.12), and EAEC alone reduced cognitive scores at 15 and 24 months of age (β = -2.82 and -5.02, respectively; CI: -5.15 to -0.48 and -9.81 to -0.22, respectively). Subclinical EAEC infection is associated with inflammation, gut dysfunction, growth failure, and cognitive delay.

    2026The American journal of tropical medicine and hygiene(2026)
    引用
    AI阅读
    加入学术空间
    3Efficacy of Early Ivermectin Administration in Acute Chikungunya Virus Infection: A Multicenter, Open-Label, Randomized Controlled Trial
    Sarunyou Chusri,Smonrapat Surasombatpattana,Pisud Siripaitoon,Narongdet Kositpantawong,Siripen Kanchanasuwan,Porntip Intapiboon,Sorawit Chittrakarn,Nattapat Sangkakul,Nonthanat Tongsengkee,Tawin Khaimook,Thanaporn Hortiwakul,Boonsri Charoenmak,

    Background: Acute and chronic joint pain is the hallmark of chikungunya virus (CHIKV) infection, often progressing to debilitating persistent joint pain. No approved antiviral therapy is available. We evaluated the clinical and virological efficacy of early ivermectin administration in acute CHIKV infection.Methods: This open-label, randomized trial enrolled and randomized 127 adult patients with acute chikungunya within 72 hours of symptom onset in Thailand. Patients were assigned (1:1) to oral ivermectin (400 µg/kg/day for 3 days) plus standard of care or standard of care alone. Before the 1-month endpoint, 7 patients were lost to follow-up, leaving a finalized complete-case cohort of 120 participants (n = 60 per arm) for primary efficacy analysis. Co-primary outcomes were time to acute joint pain clearance and the proportion of patients with persistent joint pain at 1 month.Findings: Early ivermectin significantly accelerated acute joint pain resolution compared to controls (median 3.5 days [IQR 2, 6] vs 12.0 days [IQR 8, 35]; adjusted hazard ratio (aHR) 3.65, 95% CI 2.28, 5.84; p < 0.0001). Ivermectin was associated with a 92% reduction in the odds of persistent joint pain at 1 month (6.6% vs 30%; adjusted odds ratio (aOR) 0.08, 95% CI 0.03, 0.21; p < 0.0001). It also shortened fever clearance (median 2.0 vs 5.0 days; p < 0.0001) and accelerated viral clearance by day 7.Conclusions: Early ivermectin intervention within 72 hours of symptom onset significantly accelerates clinical recovery, suppresses viral replication, and profoundly reduces persistent joint pain at 1 month. These findings position ivermectin as a promising, scalable therapeutic strategy against CHIKV.Trial registration: ClinicalTrials.gov, NCT06259383 (Retrospectively registered on February 20, 2024 prior to thawing bio-banked samples for sequential assays, laboratory assay and final analysis).Trial registration: ClinicalTrials.gov identifier: NCT06259383..

    2026Emerging Microbes and Infections(2026)
    引用
    AI阅读
    加入学术空间
    4Molecular Evidence for Infections with the Scrub Typhus Agent (orientia Tsutsugamushi) in Bird-Associated Chiggers and Ground Birds
    Praveena Rajasegaran, Jing, Sirikamon Koosakulnirand,Piyada Linsuwanon, Muhammad Al Amin Mohd-Redzuan, Youseuf Suliman,Sazaly Abubakar, Zubaidah Ya’cob,Benjamin L. Makepeace

    Orientia tsutsugamushi is an obligate intracellular bacterium responsible for scrub typhus. It exists as a symbiont within trombiculid mites, of which only the larval stage (or “chigger”) is parasitic. While the role of small mammals in maintaining this vector–pathogen cycle is well-documented, the involvement of birds as hosts for chiggers and/or O. tsutsugamushi remains understudied. Here, we screened chigger mites collected from various bird species in a scrub typhus-endemic country (Malaysia) for O. tsutsugamushi infection, together with organ and tissue samples from red junglefowl (Gallus gallus), domestic chickens (Gallus gallus domesticus) and house crows (Corvus splendens). Chiggers were pooled by species per bird host and assayed using a nested polymerase chain reaction (nPCR) targeting the htrA gene, with a subset of pools subjected to Illumina metagenomic sequencing. Leptotrombidium chiangraiensis chiggers from an O. tsutsugamushi-positive colony maintained in Thailand were used to validate the sequencing strategy. Bird tissue samples were also assayed by htrA-targeted nPCR. Illumina sequencing of pools of L. chiangraiensis from an infected colony showed good coverage across almost the entire O. tsutsugamushi genome. However, O. tsutsugamushi was not detected in pooled DNA samples from bird-associated chiggers by nPCR and neither did metagenomic analysis identify O. tsutsugamushi sequences, except in a Blankaartia acuscutellaris pool from a wild slaty-breasted rail (Lewinia striata). Multiple contigs related to Rickettsiales amplified genetic elements of Orientia origin were observed in this sample, but no core genes were assembled that could be used for strain typing. Among galliform birds and house crows, O. tsutsugamushi DNA was detected in one red junglefowl and one domestic chicken sample by nPCR, and phylogenetic analysis clustered these sequences with Karp isolates. Although Orientia infections in birds and associated chiggers appear rare, our findings suggest that these hosts may contribute to pathogen ecology and dispersal, highlighting the need for broader avian surveillance.

    2026Parasites & Vectors(2026)
    引用
    AI阅读
    加入学术空间
    5BMP-2 Mrna-Transfected BMSCs Promote Superior Calvarial Bone Regeneration
    Theeraphat Surisaeng,Wichaya Wisitrasameewong,Chantrakorn Champaiboon, Noppadol Sa-Ard-Iam, Theerapat Chanamuangkon,Peerapat Thongnuek,Ying K Tam,Hiromi Muramatsu,Drew Weissman,Norbert Pardi,Sathit Pichyangkul,Rangsini Mahanonda

    Large critical-size bone defects in the oral and craniofacial region are difficult to regenerate. We evaluated the effectiveness of mRNA encoding bone morphogenic protein-2 (BMP-2) in enhancing bone regeneration using a rat calvarial defect model. Two delivery approaches were investigated: (1) in vivo application of BMP-2 mRNA encapsulated in lipid nanoparticles incorporated in a scaffold, and (2) application of ex vivo BMP-2 mRNA-transfected rat bone marrow mesenchymal stem cells (rBMSCs), loaded on a scaffold and implanted into calvarial defects. The direct application of BMP-2 mRNA encapsulated in lipid nanoparticles improved bone regeneration as indicated by micro-computed tomography analysis. The enhancement was even more pronounced with ex vivo transfected rBMSCs. rBMSCs transfected with FGF-2 mRNA did not improve bone regeneration, either alone or combined with BMP-2 mRNA-transfected rBMSCs. Similarly, PDGF-BB mRNA-transfected rBMSCs failed to enhance bone regeneration alone and notably suppressed BMP-2 mRNA-transfected rBMSCs’ effects. Interestingly, BMP-2 mRNA-transfected rat fibroblasts showed comparable bone regeneration to transfected rBMSCs. Osteogenic differentiation was absent in BMP-2 mRNA-transfected rBMSCs, implying that they may primarily serve as a source of translated BMP-2 for bone regeneration rather than undergoing osteogenic differentiation. These findings highlight the translational potential of BMP-2 mRNA for bone regeneration, particularly in oral and craniofacial applications.

    2025Scientific reports(2025)引用:8
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1432 篇论文

    合作机构(100)

    玛希隆大学合作论文 253
    马萨诸塞大学合作论文 68
    Queen Sirikit National Institute of Child Health合作论文 65
    美国国家卫生研究院合作论文 59
    朱拉隆功大学合作论文 56
    杜克大学合作论文 52
    约翰斯·霍普金斯大学合作论文 50
    纽约州立大学合作论文 46
    弗吉尼亚大学合作论文 41
    牛津大学合作论文 38

    机构统计